
Tobias Neff/LinkedIn
Feb 23, 2025, 10:22
Tobias Neff: Mechanistic insight why stem-cell like leukemia has such poor outcomes
Tobias Neff, Executive Medical Director at Merck, shared an article by Fatemeh Alikarami, et al. on LinkedIn:
“This took 10 years to complete, very happy to see it is finally out!
Mechanistic insight why stem-cell like leukemia has such poor outcomes.
Congratulations to Fatemeh Alikarami, Kathrin Bernt and team!”
GATA2 links stemness to chemotherapy resistance in acute myeloid leukemia.
Authors: Fatemeh Alikarami, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 23, 2025, 10:13
Feb 23, 2025, 10:11
Feb 23, 2025, 10:08
Feb 23, 2025, 10:03
Feb 23, 2025, 09:45
Feb 23, 2025, 09:40
Feb 23, 2025, 09:39
Feb 23, 2025, 08:32